|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 209/52 | (2006.01) |
| C07D 209/02 | (2006.01) | ||
| C07K 7/06 | (2006.01) | ||
| C07K 5/02 | (2006.01) | ||
| C07K 5/08 | (2006.01) | ||
| C07K 5/10 | (2006.01) |
| (11) | Number of the document | 2368877 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10185132.7 |
| Date of filing the European patent application | 2001-08-31 | |
| (97) | Date of publication of the European application | 2011-09-28 |
| (45) | Date of publication and mention of the grant of the patent | 2014-05-07 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 229398 P | 2000-08-31 | US | |
| 277641 P | 2001-03-21 | US |
| (72) |
Babine, Robert Edward, US
Chen, Shu-Hui, US
Lamar, Jason Eric, US
Snyder, Nancy June, US
Sun, Xicheng, US
Tebbe, Mark Joseph, DE
Victor, Frantz, US
Wang, May Q., US
Yip, Mai Yee Yvonne, US
Collado, Ivan, ES
Garcia-Paredes, Cristina, ES
Parker III, Samuel Raymond, US
Jin, Ling, US
Guo, Deqi, US
Glass, John Irvin, US
|
| (73) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, Boston, MA 02210,
US
|
| (54) | Peptidomimetic protease inhibitors and intermediates for their preparation As treatment for HCV infection |
| Peptidomimetic protease inhibitors and intermediates for their preparation As treatment for HCV infection |